Atara Biotherapeutics, Inc Earning Date (ATRA)

USA |NASDAQ |USD

ATRA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 28, 2022 Dec 2021 $-0.75 $-0.90 $-0.95
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 28, 2022 Dec 2021 $27.48M $5.37M $0.00

Atara Biotherapeutics, Inc's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 2021.

ATRA Earnings Date & History Chart

ATRA Earnings & Revenue Forecast

ATRA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 6 $-0.93 $-1.03 $-0.74
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $-3.36 $-3.70 $-2.89

ATRA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.90 $-0.91 $-0.87
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-3.37 $-3.55 $-3.49

ATRA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 5 $8.03M $5.00M $17.87M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $50.07M $22.66M $73.70M

ATRA Earnings Date & Revenue History

ATRA Earnings History

|
Show More
Show More

ATRA Revenue History

|
Show More
Show More

Atara Biotherapeutics, Inc Next Earnings Date & Report

ATRA Next Earnings Date & Report Preview: Dec 2021 (FQ)

ATRA's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 7 analysts, the average EPS estimation for Atara Biotherapeutics, Inc's next quarterly earnings is $-0.75, with a low EPS estimation of $-1.12, and a high estimation of $-0.49.

Over the last 1 month, EPS estimates have seen 3 upward revisions and 0 downward. The EPS 1 month trend is $-0.75, the last 2 month trend is $-0.98, and the 3 month trend is $-0.95.

Based on 8 analysts, the average revenue estimation is $27.48M, with a low revenue estimation of $4.00M, and a high estimation of $50.60M.

Atara Biotherapeutics, Inc Previous Earnings Dates & Reports

ATRA Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Atara Biotherapeutics, Inc's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.

ATRA's earnings per share (EPS) was $-0.90, beating the consensus analysts forecast of $-0.94 by 3.96%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -1.10%, and higher than the same period a year before (Sep 2020) by -2.17%.

Revenues were $5.37M.

The company reported a net income of $-84.66M.

Free cash flow for the quarter was $-62.83M , compared to $-63.64M last quarter and $-53.46M a year before.

ATRA ended the quarter with $24.57M in total debt, an increase of 101.72% compared to the previous quarter, and an increase of 87.17% compared to the same quarter a year before.

ATRA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Atara Biotherapeutics, Inc's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

ATRA's earnings per share (EPS) was $-4.21, missing the consensus analysts forecast of $-3.93 by 7.12% , and higher than the previous year's EPS (Dec 2019) by -26.27%.

Revenues were $0.00.

The company reported a net income of $-306.62M.

Atara Biotherapeutics, Inc reported a free cash flow of $-185.27M for its fiscal year, compared to $-241.36M a year ago.

The company ended the fiscal year with $15.03M in total debt, a decrease of -4.40% compared to the previous year.